Antianxiety effect of cannabidiol in the elevated plus-maze

Antianxiety effect of cannabidiol in the elevated plus-maze Guimarães FS, Chiaretti TM, Graeff FG, Zuardi AW 1990 Psychopharmacology CBD PMID: 1969666 Citation Count: 207 H5 Index: n/a SJR: n/a Keywords & Tags: Anxiety, Animal Trial, CBD, Neuropsychiatric Disorders, anxiolytic, Diazepan, elevated plus-maze model of anxiety Animal trial Anxiety Neuropsychiatric Disorders Participants: n/a Dosage: 2.5, 5.0, 10.0 and 20.0 … Continue reading Antianxiety effect of cannabidiol in the elevated plus-maze